- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.53 Å
- Oligo State
- monomer
- Ligands
- 1 x ZLK: zafirlukast(Non-covalent)
- 8 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)
OLC.2: 3 residues within 4Å:- Chain A: F.145, G.149, F.153
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.145, A:F.153
OLC.3: 3 residues within 4Å:- Chain A: F.153, L.156, V.195
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.153, A:L.156, A:V.195
OLC.4: 5 residues within 4Å:- Chain A: V.39, G.43, C.401, P.404, L.405
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:V.39, A:P.404, A:L.405, A:L.405
OLC.5: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)OLC.6: 3 residues within 4Å:- Chain A: M.348, T.351
- Ligands: OLA.12
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:T.351
OLC.7: 4 residues within 4Å:- Chain A: Y.194, F.198, T.366, H.370
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:Y.194, A:F.198, A:T.366
- Salt bridges: A:H.370
OLC.8: 6 residues within 4Å:- Chain A: L.32, M.35, I.36, L.395, S.398, C.401
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.32, A:L.32, A:I.36, A:L.395
OLC.9: 6 residues within 4Å:- Chain A: F.122, I.126, I.207, V.210, C.211, M.214
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.126, A:I.207, A:V.210, A:V.210
- 11 x OLA: OLEIC ACID(Non-covalent)
OLA.10: 4 residues within 4Å:- Chain A: G.345, M.348, F.408, F.409
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:M.348, A:F.409, A:F.409
- Hydrogen bonds: A:F.409
OLA.11: 3 residues within 4Å:- Chain A: V.83, V.84, H.88
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.83, A:V.84
- Salt bridges: A:H.88
OLA.12: 6 residues within 4Å:- Chain A: I.216, L.219, S.223, H.340, I.344
- Ligands: OLC.6
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:I.216
- Hydrogen bonds: A:L.219, A:S.223
OLA.13: 9 residues within 4Å:- Chain A: V.63, N.67, V.70, L.74, Y.104, R.144, C.147, W.151, I.155
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:V.70, A:L.74, A:Y.104, A:W.151, A:W.151, A:W.151, A:I.155
- Hydrogen bonds: A:N.67
OLA.14: 5 residues within 4Å:- Chain A: K.186, N.187, H.188, V.189
- Ligands: OLA.15
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:V.189
- Hydrogen bonds: A:N.187, A:H.188
- Salt bridges: A:K.186, A:H.188
OLA.15: 3 residues within 4Å:- Chain A: L.192
- Ligands: ZLK.1, OLA.14
No protein-ligand interaction detected (PLIP)OLA.16: 5 residues within 4Å:- Chain A: N.187, L.190, V.191, Y.194, F.198
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.190, A:Y.194, A:F.198
- Hydrogen bonds: A:N.187
OLA.17: 3 residues within 4Å:- Chain A: T.213, M.214, L.217
No protein-ligand interaction detected (PLIP)OLA.18: 3 residues within 4Å:- Chain A: F.115, T.118, F.122
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.115, A:T.118, A:F.122
OLA.19: 3 residues within 4Å:- Chain A: T.351, L.355, M.359
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:T.351, A:L.355
OLA.20: 2 residues within 4Å:- Chain A: L.220, S.223
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.220
- Hydrogen bonds: A:S.223
- 1 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Luginina, A. et al., Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs. Sci Adv (2019)
- Release Date
- 2019-10-30
- Peptides
- Cysteinyl leukotriene receptor 1,Soluble cytochrome b562,Cysteinyl leukotriene receptor 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.53 Å
- Oligo State
- monomer
- Ligands
- 1 x ZLK: zafirlukast(Non-covalent)
- 8 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)
- 11 x OLA: OLEIC ACID(Non-covalent)
- 1 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Luginina, A. et al., Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs. Sci Adv (2019)
- Release Date
- 2019-10-30
- Peptides
- Cysteinyl leukotriene receptor 1,Soluble cytochrome b562,Cysteinyl leukotriene receptor 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.